| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 307,543 | 304,499 | 223,478 | 199,580 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit |
-
| 304,499 | 223,478 | 199,580 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 177,409 | 272,258 | 156,109 | 241,958 | | Non Recurring |
-
| (71,963) | 71,963 |
-
| | Others | 4,103 | 19,149 | (8,669) |
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 23,544 | 29,326 | 4,075 | (42,378) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (96,371) | (42,681) |
-
| 18,334 | | Earnings Before Interest And Taxes | 29,660 | 41,045 | 5,404 | (13,024) | | Interest Expense | 6,116 | 6,116 | 6,932 | 6,204 | | Income Before Tax | 23,544 | 34,929 | (1,528) | (19,228) | | Income Tax Expense | 7,802 | 11,982 | (1,256) | (11,028) | | Minority Interest | 33 | 92 |
-
| 40 | | | | Net Income From Continuing Ops | 15,742 | 24,203 | (1,528) | (19,228) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 15,915 | 24,456 | (1,528) | (19,228) | | Preferred Stock And Other Adjustments |
-
| (38) | 38 | 112 | | | Net Income Applicable To Common Shares | $15,915 | $24,418 | ($1,490) | ($19,116) |
|
0.51% Nasdaq 
0.04 (0.22%) 
Income Statement
